We are looking for Data Visualization Expert
Due to our business growth, we are looking for an experienced DATA VISUALIZATION EXPERT Your task will be to make social and health economic and
6.5.2020
Two new PhDs to complement ESiOR expertise
Two of ESiOR’s employees, Senior Consultant Saku Väätäinen and Consultant, Market Access Manager Saara Huoponen, have completed their doctoral studies and received doctoral degrees in
4.5.2020
Welcome! Christian and Roope
We are happy to welcome Dr. Christian Asseburg – Director, Evidence Generation – and Roope Metsä – Junior Consultant! We are thrilled to have our
7.10.2019
Multicentre research of Crohn’s disease
Register studies with excellent coverage and deep data are possible in Finland Nationwide noninterventional, retrospective chart review explored real-life characteristics and outcomes of patients with
21.8.2019
StopDia investment estimation
Web-based interactive estimation app: assessment of potential incidence and cost effects related to intervention StopDia investment estimation application predicts and visualizes in simple example-type fashion
21.8.2019
eHealth2019: Five presentations
eHealth2019: Five presentations We take part in eHealth2019 – International Conference 2019 & The 24th Finnish National Conference on Telemedicine and eHealth “Data-Driven Health” in
22.3.2019
Welcome Tuomas Lundström
ESiOR Oy experience is increasing… We welcome the 12th member of our team. Tuomas Lundström has joined our team as consultant and data scientist. Tuomas
19.10.2018
SHEOG: cost-effectiveness group @LinkedIn
Social and Health Economics and Outcomes Group (SHEOG) @LinkedIn https://www.linkedin.com/groups/8678341 You are welcome to join SHEOG! SHEOG @LinkedIn aims to encourage discussion about economic evaluation
25.6.2018
Virtual hospital 2.0 and Isaacus: presentations March 15, 2018
Virtual Hospital 2.0 mid-assessment and Isaacus pre-production project results are presented as podiums in an international eHealth2018 congress ESiOR takes part in the international eHealth
29.1.2018
Welcome Saara Huoponen
ESiOR Oy gets stronger… We welcome the 10th member of our team! Namely, ISPOR-awarded Saara Huoponen has joined our team as health economic consultant and
11.1.2018
Cost-effectiveness and budget impact analysis including a risk-sharing scheme
Conditional reimbursement context: An economic evaluation including a risk-sharing scheme A hybrid-modeling study that evaluated the clinical outcomes, cost-effectiveness, and budget impact of biologic rheumatoid
4.12.2017
Akseli Kivioja and Satu Rauhala: stronger service portfolio at ESiOR
Well-known Market Access professionals, Satu Rauhala and Akseli Kivioja, joined ESiOR on August 7th, 2017. Their joint experience is unique: Finnish Pharmaceuticals Pricing Board, pharma industry,
10.8.2017
